The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics, treatment patterns, and outcomes of common solid tumors in Arab American patients.
 
Shadi Chamseddine
No Relationships to Disclose
 
Yingnan Zhang
No Relationships to Disclose
 
Yang Shi
No Relationships to Disclose
 
Hadeel Assad
Honoraria - Gilead Sciences; Menarini
Consulting or Advisory Role - Daiichi Sankyo
Speakers' Bureau - Gilead Sciences; Stemline Therapeutics
 
Philip Philip
Honoraria - Astellas Pharma; Bayer; BioNTech SE; incyte; Ipsen; Novocure; Seagen; SERVIER; Taiho Pharmaceutical; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Ipsen; Merck; SynCoreBio; Taiho Pharmaceutical; TriSalus Life Sciences
Speakers' Bureau - Incyte
Research Funding - Bayer (Inst); BioNTech SE (Inst); Genentech (Inst); halozyme (Inst); incyte (Inst); Lilly (Inst); Merck (Inst); merus (Inst); novartis (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
(OPTIONAL) Uncompensated Relationships - Caris MPI; Rafael Pharmaceuticals
 
Morhaf Al Achkar
No Relationships to Disclose
 
Lawrence Flaherty
No Relationships to Disclose
 
Rafic Beydoun
No Relationships to Disclose
 
Wael Sakr
No Relationships to Disclose
 
Asfar Azmi
Consulting or Advisory Role - Gerson Lehrman Group; Guidepoint Inc
Research Funding - Blackstone Therapeutics; Colorado chromatography; FanWave; Purple Biotech
 
Khalil Choucair
No Relationships to Disclose